• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合并症和体重指数对非裔美国人和高加索裔结肠癌患者生存的影响。

Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer.

机构信息

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama 35294-7331, USA.

出版信息

Cancer. 2009 Dec 15;115(24):5798-806. doi: 10.1002/cncr.24598.

DOI:10.1002/cncr.24598
PMID:19937953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2795032/
Abstract

BACKGROUND

There is a survival disparity between African Americans and Caucasians who have colon cancer. The objectives of the current study were to quantify the impact of comorbidity and body mass index (BMI) on survival and to assess whether these 2 variables account for the decreased survival among African Americans.

METHODS

Data from patients (n=496) who underwent surgery for a first primary colon cancer at the University of Alabama at Birmingham Hospital from 1981 to 2002 were analyzed. Hazard ratios (HRs) with 95% confidence intervals (CI) were obtained using Cox proportional hazards models for the association of race, comorbidity, BMI, and covariates with all-cause mortality. The confounding influence of comorbidity and BMI for the increased risk of death associated with African-American race was evaluated, and effect modification by disease stage for the association of comorbidity and BMI with mortality also was assessed.

RESULTS

African Americans experienced an increased risk of death compared with Caucasians (HR, 1.34; 95% CI, 1.06-1.68). The highest comorbidity burden was associated with an increased risk of all-cause mortality (HR, 1.63; 95% CI, 1.24-2.15). For BMI, being underweight increased the risk of death (HR, 1.54; 95% CI, 0.96-2.45); however, being overweight/obese was protective (HR, 0.77; 95% CI, 0.61-0.97). The effect of comorbidity was observed among those with early stage tumors, whereas the effect of BMI was confined to patients who had advanced tumors.

CONCLUSIONS

Although comorbidity and BMI had an impact on the survival of patients with colon cancer after surgery, these variables were not contributing factors to the decreased survival observed among African Americans.

摘要

背景

非裔美国人和白种人患有结肠癌的存活率存在差异。本研究的目的是量化合并症和体重指数(BMI)对存活率的影响,并评估这两个变量是否导致非裔美国人存活率降低。

方法

分析了 1981 年至 2002 年在阿拉巴马大学伯明翰分校医院接受首次原发性结肠癌手术的 496 名患者的数据。使用 Cox 比例风险模型获得种族、合并症、BMI 和协变量与全因死亡率之间关联的风险比(HR)和 95%置信区间(CI)。评估了合并症和 BMI 对与非裔美国人种族相关的死亡风险增加的混杂影响,并评估了疾病分期对合并症和 BMI 与死亡率之间关联的效应修饰作用。

结果

与白种人相比,非裔美国人的死亡风险增加(HR,1.34;95%CI,1.06-1.68)。合并症负担最高与全因死亡率增加相关(HR,1.63;95%CI,1.24-2.15)。对于 BMI,体重不足会增加死亡风险(HR,1.54;95%CI,0.96-2.45);然而,超重/肥胖是保护性的(HR,0.77;95%CI,0.61-0.97)。合并症的影响仅见于早期肿瘤患者,而 BMI 的影响仅限于晚期肿瘤患者。

结论

尽管合并症和 BMI 对结肠癌患者手术后的生存有影响,但这些变量并不是导致非裔美国人存活率降低的因素。

相似文献

1
Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer.合并症和体重指数对非裔美国人和高加索裔结肠癌患者生存的影响。
Cancer. 2009 Dec 15;115(24):5798-806. doi: 10.1002/cncr.24598.
2
Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma.非洲裔美国人和患有结肠腺癌的白种人术后生存率的差异。
Cancer. 2004 Jul 1;101(1):66-76. doi: 10.1002/cncr.20337.
3
High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas.高分化肿瘤是非洲裔美国结肠腺癌患者预后不良的一个指标。
Cancer. 2005 May 15;103(10):2163-70. doi: 10.1002/cncr.21021.
4
Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.癌症分期和治疗差异对结肠癌生存种族差异的影响:一项基于美国人群的研究
Gastroenterology. 2016 May;150(5):1135-1146. doi: 10.1053/j.gastro.2016.01.030. Epub 2016 Feb 2.
5
Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults.老年人中接受奥沙利铂治疗 III 期结肠癌的种族差异及其疗效比较。
Cancer. 2012 Jun 1;118(11):2925-34. doi: 10.1002/cncr.26622. Epub 2011 Nov 9.
6
Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma.患有结肠腺癌的非裔美国人和白种人术后生存率的差异。
Cancer. 2004 Dec 15;101(12):2899; author reply 2900. doi: 10.1002/cncr.20702.
7
Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer.一项针对结肠癌的随机辅助化疗试验中非洲裔美国患者和白种人患者的疗效与毒性
J Natl Cancer Inst. 2002 Aug 7;94(15):1160-7. doi: 10.1093/jnci/94.15.1160.
8
Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.接受化疗的 II 期和 III 期结肠癌黑人患者的结局:ACCENT 辅助试验分析。
J Natl Cancer Inst. 2011 Oct 19;103(20):1498-506. doi: 10.1093/jnci/djr310. Epub 2011 Oct 12.
9
Impact of race/ethnicity on prognosis in patients who underwent surgery for colon cancer: analysis for white, African, and East Asian Americans.种族/民族对接受结肠癌手术患者预后的影响:白种人、非裔美国人和东亚裔美国人的分析。
Ann Surg Oncol. 2012 May;19(5):1517-28. doi: 10.1245/s10434-011-2113-5. Epub 2011 Oct 20.
10
Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer.在一个基于人群的大型老年结肠癌患者队列中,种族差异和社会经济地位与生存情况的关联。
Cancer. 2007 Aug 1;110(3):660-9. doi: 10.1002/cncr.22826.

引用本文的文献

1
The obesity pandemic and its impact on non-communicable disease burden.肥胖症大流行及其对非传染性疾病负担的影响。
Pflugers Arch. 2025 May;477(5):657-668. doi: 10.1007/s00424-025-03066-8. Epub 2025 Feb 10.
2
Chronic obesity does not alter cancer incidence in mice.慢性肥胖不会改变小鼠的癌症发病率。
bioRxiv. 2025 Mar 17:2024.10.14.618190. doi: 10.1101/2024.10.14.618190.
3
Immunotherapy and Overall Survival Among Patients With Advanced Non-Small Cell Lung Cancer and Obesity.免疫疗法与肥胖的晚期非小细胞肺癌患者的总生存。
JAMA Netw Open. 2024 Aug 1;7(8):e2425363. doi: 10.1001/jamanetworkopen.2024.25363.
4
Mendelian randomization unraveled: gender-specific insights into obesity-related phenotypes and colorectal cancer susceptibility.孟德尔随机化揭示:肥胖相关表型和结直肠癌易感性的性别特异性见解。
Front Endocrinol (Lausanne). 2024 Jun 6;15:1322253. doi: 10.3389/fendo.2024.1322253. eCollection 2024.
5
Exploring the optimal indicator of short-term peridiagnosis weight dynamics to predict cancer survival: A multicentre cohort study.探索预测癌症生存的短期围诊断体重动态最佳指标:一项多中心队列研究。
J Cachexia Sarcopenia Muscle. 2024 Jun;15(3):1177-1186. doi: 10.1002/jcsm.13467. Epub 2024 Apr 21.
6
Predicting the risk of neurocognitive decline after brain irradiation in adult patients with a primary brain tumor.预测原发性脑肿瘤成人患者脑照射后神经认知下降的风险。
Neuro Oncol. 2024 Aug 5;26(8):1467-1478. doi: 10.1093/neuonc/noae035.
7
New role of fat-free mass in cancer risk linked with genetic predisposition.瘦体重与遗传易感性在癌症风险中的新作用。
Sci Rep. 2024 Mar 27;14(1):7270. doi: 10.1038/s41598-024-54291-7.
8
The mortality risk in patients with early onset colorectal cancer: the role of comorbidities.早发性结直肠癌患者的死亡风险:合并症的作用。
Front Oncol. 2023 Apr 14;13:1139925. doi: 10.3389/fonc.2023.1139925. eCollection 2023.
9
The safety and prognosis of radical surgery in colorectal cancer patients over 80 years old.80 岁以上结直肠癌患者根治性手术的安全性和预后。
BMC Surg. 2023 Feb 28;23(1):45. doi: 10.1186/s12893-023-01938-3.
10
Anatomic location of colorectal cancer presents a new paradigm for its prognosis in African American patients.结直肠癌的解剖位置为非裔美国患者的预后提供了一个新的模式。
PLoS One. 2022 Jul 29;17(7):e0271629. doi: 10.1371/journal.pone.0271629. eCollection 2022.

本文引用的文献

1
THE PRE-THERAPEUTIC CLASSIFICATION OF CO-MORBIDITY IN CHRONIC DISEASE.慢性病共病的治疗前分类
J Chronic Dis. 1970 Dec;23(7):455-68. doi: 10.1016/0021-9681(70)90054-8.
2
Cancer statistics, 2008.2008年癌症统计数据。
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.
3
African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review.按数据来源分析非裔美国人和白种人在结直肠癌死亡率及生存率方面的差异:一项流行病学综述
Cancer Biomark. 2007;3(6):301-13. doi: 10.3233/cbm-2007-3604.
4
Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidity.基于人群的结直肠癌生存种族/民族差异纵向研究:邻里社会经济地位、治疗及合并症的影响
BMC Cancer. 2007 Oct 16;7:193. doi: 10.1186/1471-2407-7-193.
5
Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies.肥胖与结直肠癌风险:前瞻性研究的荟萃分析
Am J Clin Nutr. 2007 Sep;86(3):556-65. doi: 10.1093/ajcn/86.3.556.
6
Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.接受结肠癌辅助化疗患者的体重指数与预后
J Natl Cancer Inst. 2006 Nov 15;98(22):1647-54. doi: 10.1093/jnci/djj442.
7
Colorectal cancer model of health disparities: understanding mortality differences in minority populations.结直肠癌健康差异模型:理解少数族裔人群的死亡率差异
J Clin Oncol. 2006 May 10;24(14):2179-87. doi: 10.1200/JCO.2005.05.4775.
8
Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites.结直肠癌与种族:了解非裔美国人和白人在治疗结果上的差异。
Med Clin North Am. 2005 Jul;89(4):771-93. doi: 10.1016/j.mcna.2005.03.001.
9
Severe comorbidity negatively influences prognosis in patients with oral and oropharyngeal cancer after surgical treatment with microvascular reconstruction.严重合并症对口腔和口咽癌患者微血管重建手术后的预后产生负面影响。
Oral Oncol. 2005 Apr;41(4):358-64. doi: 10.1016/j.oraloncology.2004.08.012.
10
Differential prognostic impact of comorbidity.合并症的不同预后影响。
J Clin Oncol. 2004 Aug 1;22(15):3099-103. doi: 10.1200/JCO.2004.08.040.